|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows From Operating Activities | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | |||||
| Realized loss on RMBS, net | |||||
| Unrealized loss on investments in Servicing Related Assets | |||||
| Realized gain on investments in MSRs, net | |||||
| Realized gain on acquired assets, net | |||||
| Realized gain on derivatives, net | |||||
| Unrealized (gain) loss on RMBS, measured at fair value through earnings, net | |||||
| Unrealized (gain) loss on derivatives, net | |||||
| Accretion of premiums on RMBS | |||||
| Amortization of deferred financing costs | |||||
| LTIP-OP Unit awards | |||||
| Changes in operating assets and liabilities: | |||||
| Decrease (increase) in receivables and other assets | |||||
| Decrease in due to manager | |||||
| Increase (decrease) in accrued expenses and other liabilties | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash Flows From Investing Activities | |||||
| Purchase of RMBS | |||||
| Principal paydown of RMBS | |||||
| Proceeds from sale of RMBS | |||||
| Proceeds from sale of MSRs | |||||
| Acquisition of MSRs | |||||
| Payments for settlement of derivatives | |||||
| Proceeds from (payments for) settlement of derivatives | |||||
| Net cash used in investing activities | |||||
| Cash Flows From Financing Activities | |||||
| Borrowings under repurchase agreements | |||||
| Repayments of repurchase agreements | |||||
| Proceeds from derivative financing | |||||
| Payments for bank loans | |||||
| Principal paydown of bank loans | |||||
| Dividends paid | |||||
| LTIP-OP Units distributions paid | |||||
| Conversion of OP units | |||||
| Redemption of OP units | |||||
| Issuance of common stock, net of offering costs | |||||
| Repurchase and retirement of preferred stock | |||||
| Net cash provided by financing activities | |||||
| Net Increase (Decrease) in Cash, Cash Equivalents and Restricted Cash | |||||
| Cash, Cash Equivalents and Restricted Cash, Beginning of Period | |||||
| Cash, Cash Equivalents and Restricted Cash, End of Period | |||||
| Supplemental Disclosure of Cash Flow Information | |||||
| Cash paid during the period for interest expense | |||||
| Cash paid during the period for income taxes | |||||
| Supplemental Schedule of Non-Cash Investing and Financing Activities | |||||
| Dividends declared but not paid | |||||
| Sale of RMBS, settled after period end | |||||
| Purchase of RMBS, settled after period end | |||||
| Reconciliation of cash and cash equivalents and restricted cash | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
Loading...